[Molecular mechanism underlying differentiation of HL-60 cells induced by hexamethylene bisacetamide]. 2008

Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
Institute of Basic Medical Sciences, Shandong Academy of Medical Sciences, Jinan 250062, Shangdong Province, China.

The objective of this study was to investigate the effect of hexamethylene bisacetamide (HMBA) on differentiation of HL-60 cells and its possible molecular mechanism. HL-60 cells were co-cultured with different concentrations of HMBA (0.5, 1, 2 mmol/L) for 4 days, then the proliferation was assayed by MTT at different time points. Wright-Giemsa staining was used to observe the change in morphology. Cell differentiation antigen CD11b expression and the altered distribution of cell cycle in HL-60 induced by HMBA were analyzed by flow cytometry. The expressions of c-myc, mad1, p21, p27, hTERT and HDAC1 mRNA were detected by RT-PCR. The results indicated that the proliferation of HL-60 cells was inhibited by HMBA in a time-and-dose-dependent manner. Upon 2 mmol/L HMBA treatment, the HL-60 cells arrested at G(0)/G(1) phase and differentiated into granular line in morphology, with the up-regulation of CD11b expression. The expression of c-myc and hTERT mRNA obviously down-regulated, the expression of p21, p27 and mad1 mRNA up-regulated, while there was no change of the expression of hTERT mRNA. It is concluded that effect of HMBA on the differentiation of HL-60 cells may partly contribute to switch from c-myc to mad1 expression, to up-regulate expressions of p21 and p27 mRNA, and down-regulate hTERT mRNA expression, while there is no relation with the expression of HDAC1 mRNA.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell

Related Publications

Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
July 1988, International journal of cell cloning,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
January 1997, Journal of chromatography. B, Biomedical sciences and applications,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
February 2007, Experimental hematology,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
June 1977, Biochemical and biophysical research communications,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
January 1990, Folia haematologica (Leipzig, Germany : 1928),
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
October 2003, Zhongguo shi yan xue ye xue za zhi,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
March 1989, Environmental health perspectives,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
March 1986, Cancer research,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
May 1987, Cancer treatment reports,
Xia Ren, and Pei-E Wen, and Wei-Hua Yang, and Tian-Hua Tang, and Hai-Quan Ren, and Zhi-Yong Zhang, and Hai-Tao Zhao, and Hua Fan, and Gao-Juan Qiao, and Guo-Heng Jiang
January 1987, Progress in clinical and biological research,
Copied contents to your clipboard!